Targeted molecular therapy for Myocardial Infarction: HMGA2 improves myocardial function after myocardial infarction via up regulation of its target gene, 19/August/2014, 08.03 am

Targeted molecular therapy for Myocardial Infarction: HMGA2 improves myocardial function after myocardial infarction via up regulation of its target gene, 19/August/2014, 08.03 am

Targeted molecular therapy for Myocardial Infarction: HMGA2 improves myocardial function after myocardial infarction via up regulation of its target gene, 19/August/2014, 08.03 am 150 150 Dr Boomi's Genom-2-Discovery Center

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

Citation: Boominathan, Targeted molecular therapy for Myocardial Infarction: HMGA2 improves myocardial function after myocardial infarction via up regulation of its target gene, 19/August/2014, 08.03 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Web: http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

Pharmacological relevance: This study suggests that pharmacological formulations encompassing “HMGA2 activators” may improve  myocardial function after myocardial infarction
 * Research cooperation